New Understanding of "Cancer Toxic’s Dissemination and Setting Down" Theory and ItsApplication in the Prevention and Treatment of Recurrence and Metastasis of Lung Cancer

Zhong Jia; Liu Hua; Wang Lihuai; Sun Tonglin

doi:10.11954/ytctyy.202203024

Suggestions

您当前的位置：

首页 >

文章列表页 >

New Understanding of "Cancer Toxic’s Dissemination and Setting Down" Theory and ItsApplication in the Prevention and Treatment of Recurrence and Metastasis of Lung Cancer

Previous: Analysis of Cheng Hongliang＇s syndrome differentiation in treating cervical vertigo

Next: 无

New Understanding of "Cancer Toxic’s Dissemination and Setting Down" Theory and ItsApplication in the Prevention and Treatment of Recurrence and Metastasis of Lung Cancer
1.Hunan University of Chinese Medicine, Changsha 410208, China;
2.The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha 410007, China
DOI：10.11954/ytctyy.202203024

扫描看全文

Zhong Jia, Liu Hua, Wang Lihuai, et al. New Understanding of "Cancer Toxic’s Dissemination and Setting Down" Theory and ItsApplication in the Prevention and Treatment of Recurrence and Metastasis of Lung Cancer[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.11954/ytctyy.202203024
DOI：

Zhong Jia, Liu Hua, Wang Lihuai, et al. New Understanding of "Cancer Toxic’s Dissemination and Setting Down" Theory and ItsApplication in the Prevention and Treatment of Recurrence and Metastasis of Lung Cancer[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.11954/ytctyy.202203024 DOI：

摘要

“传舍”源自《内经》，周仲瑛教授首倡“癌毒”学说，“癌毒传舍”是现代中医认识肿瘤复发转移的一种理论，刘华教授关于“癌毒传舍”新认识如下：“癌毒形成，亦禀自先天”“传舍”之“舍”含肿瘤复发，“癌毒”挟“痰”而易“传”，裹“瘀”而易“舍”。“癌毒传舍”理论应用于防治肺癌复发转移，核心理念是以和为贵，以平为期，治疗原则为扶正抗癌，防“传”拒“舍”；脾肾互赞，先后相资；或化或消，以祛他邪；治疗重点在病证结合，中西医相辅，诸法相成。

Abstract

This article introduces new view of "cancer toxin’s dissemination and setting down" . "Inheritance" is one of the factors of cancer toxin’s formation and meaning of "setting down" include recurrence. The treatment philosophy is that seeking for the harmony of the body, and the treatment methods are to reinforce healthy Qi, anti-cancer toxic and eliminate the other pathogenic factors; the points of treatment are combination of differentiation of disease and syndrome, cooperation of Chinese and Western therapy, and mutual integration of all methods.

关键词

肺癌癌毒传舍癌症复发癌症转移

Keywords

Lung CancerCancer ToxicCancer RecurrenceCancer Metastasis

references

RUSCH V W, CHANSKY K, KINDLER H L, et al. The IASLC mesothelioma staging project: proposals for the descriptors and for revision of the TNM stage groupings in the forth coming (Eighth) edition of the TNM classification for mesothelioma[J]. J Thorac Oncol, 2016, 11 (12): 2112-2119.

赵智强, 李嘉. 略论周仲瑛教授的“癌毒”学说及其临床运用[J]. 新中医, 1998, 30(10): 7-9.

上官端丹. “癌毒”理论的内涵及其辨治恶性肿瘤方法的探讨[D]. 南京: 南京中医药大学, 2017.

岳小强. 对“癌毒”定义的再认识[J]. 中西医结合学报, 2010, 8(9): 829-831.

张青, 王笑民. 基于“癌毒”的肿瘤发生发展规律探讨[C]//中国中西医结合学会肿瘤专业委员会. 第三届国际中医、中西医结合肿瘤学术交流大会暨第十二届全国中西医结合肿瘤学术大会论文汇编. 宁波: 中国中西医结合学会肿瘤专业委员会, 2010.

程海波, 吴勉华. 周仲瑛教授“癌毒”学术思想探析[J]. 中华中医药杂志, 2010, 25(6): 866-869.

郭建辉. 周仲瑛教授“癌毒学说”新论[J]. 湖南中医药大学学报, 2010, 30(11): 6-8.

郭建辉, 王志英. 周仲瑛从癌毒论治肺癌学术思想举要[J]. 辽宁中医杂志, 2012, 39(3): 410-411.

张健, 张淑贤. 中医传舍理论与肿瘤转移[J]. 中国中医基础医学杂志, 1999, 5(6): 5-7.

索凤茹. 邪毒传舍－经络流注与恶性肿瘤转移[J]. 实用中医内科杂志, 2014, 28(5): 65-66.

杨霖, 王笑民, 杨国旺, 等. 肺癌“传舍”之“传”与“舍”[J]. 中医学报, 2017, 32(6): 918-920.

张兆洲, 李琦. 癌毒传舍的中医病机初探[J]. 中华中医药杂志, 2018, 33(11): 4839-4843.

范洪桥, 刘丽芳, 熊家青, 等. 从中医学角度探讨护场与恶性肿瘤的传舍[J]. 辽宁中医杂志, 2019, 46(9): 1853-1854.

孙海霞. 脾肾互赞的理论渊源及其对后世的影响[J]. 山西中医学院学报, 2007, 9(3): 14-15.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Dong's Extraordinary Points in the Treatment of Advanced Lung Cancer Pain for Two Cases

LIN Hongsheng's Clinical Experience in the Treatment of Lung Cancer with the Method of Softening Hardness and Dissipating Mass

Application of "metal-water generating" theory in malignant pleural effusion of lung cancer

Exploration on connotation of Zhigancao Decoction formula syndrome from the perspective of modern pathophysiology and severe cases of critical care and its clinical efficacy on cardioversion, maintenance of sinus rhythm, hemostasis, increasing platelets count, and tonifying deficiency

Experience of LIU Wei-Sheng in Treating Yin-deficiency with Toxin and Heat Type of Lung Cancer

Related Author

No data

Related Institution

Department of Oncology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences

China Academy of Chinese Medical Sciences

Beijing University of Chinese Medicine

Dongfang Hospital of Beijing University of Chinese Medicine

⁰